Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers in the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) reveal supramolecular attack particles are autonomous killing entities released from cytotoxic T lymphocytes

Cryo-soft-x-ray tomography projection of a CD8+ T cell interacting with a carbon coated EM grid containing ICAM-1 and anti-CD3e (left). SMAPs (middle) can be observed within the multicore granules inside the cell. dSTORM images of an individual SMAP positive for perforin (green), WGA (orange) and granzyme B (magenta) released by CD8+ T cells (right)

Scientists at the Kennedy Institute of Rheumatology in the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) have discovered a new way for T cells to attack cells infected by viruses or deranged by cancer.

Published online by the journal Science on Thursday 7 May 2020, the new research from the Dustin Group describes the structure and composition of supramolecular attack particles (SMAPs) and their role in killing targeted cells.

Cytotoxic T lymphocytes (CTLs) are essential components in the immune response against viruses and cancer. CTLs are known to recognise infected or damaged cells and release soluble protein molecules, which create perforations in the membrane of the targeted cell. These holes allow toxic enzymes to enter and initiate a self-destruct program, killing the targeted cell (cytotoxicity).

The new study reveals a complementary mechanism of cytotoxicity in the CTLs. The team identified SMAPs, ~120 nm diameter protein particles released by CTLs to kill other cells, for example, if virally infected or cancerous. SMAPs have a core of cytotoxic proteins surrounded by a glycoprotein shell.

Read more on the NDORMS website

Similar stories

Oxford Researchers elected to Royal Society

Awards and Appointments General

Six scientists from the University of Oxford, including Professor Adrian Hill and Professor Frances Platt from the Medical Sciences Division, have joined the Royal Society as Fellows.

Student Prizes for Biomedical Sciences and Medicine 2020-2021

Awards and Appointments General

Congratulations to all our Biomedical Sciences students and Medicine students who have been awarded prizes during the 2020-2021 academic year.

Multi-partner 'OpenMind' consortium to develop technology for new generation of neurostimulation devices

General Research

Investigators at the University of Oxford, University of California San Francisco (UCSF), Brown University and the Mayo Clinic have joined forces to develop open-source technology platforms for a new generation of neurostimulation devices that not only provide stimulation to the brain but also sense, record, and stream brain activity.

Why we must expand newborn screening

General Research

Professor Laurent Servais of the Department of Paeditrics writes for the Oxford Science Blog on why it is important that we become much more efficient in the diagnosis of treatable conditions and in the treatment of these diseases.

Top place for Oxford Clinical Medical Student in prestigious national Ophthalmology Duke Elder Prize Examination

Awards and Appointments General

Sixth year Clinical Medical student, Ryan Purdy (Worcester College), placed first in the Royal College of Ophthalmology's annual Prize Examination.